Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

neoadjuvant chemotherapy

  • Open Access
    Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters
    Song Gao, Yuexiang Liang, Jun Yu, Shaofei Chang, Hongwei Wang, Tiansuo Zhao, Xiuchao Wang, Quan Man, Zhifei Li, Yiping Zou, Kuirong Jiang, Chuntao Gao and Jihui Hao
    Cancer Biology & Medicine November 2025, 22 (11) 1405-1422; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0213
  • You have access
    The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
    Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang and Yingying Xu
    Cancer Biology & Medicine May 2022, 19 (5) 755-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0800
  • You have access
    Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer
    Chunfa Chen, Yuling Zhang, Ziyi Huang, Jundong Wu, Wenhe Huang and Guojun Zhang
    Cancer Biology & Medicine August 2019, 16 (3) 575-586; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0423
  • You have access
    Response and Long-Term Effect of Patients with Triple-Negative Breast Cancer Receiving Neo-Adjuvant Anthracycline-Based Chemotherapy
    Zhengkui Sun, Xingtian Ma, Yudong Wu, Fan Fan, Xianghua Wan and Airong Fu
    Clinical Oncology and Cancer Research June 2009, 6 (3) 197-202; DOI: https://doi.org/10.1007/s11805-009-0197-5
  • You have access
    Clinical Implications of HER-2 and P53 in Taxane-Based and Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
    Xiaolan Wang, Fan Yao, Nan Liu, Yunfei Wu, Xinyu Zheng, Jiguang Li, Caigang Liu, Xueshan Qiu and Feng Jin
    Chinese Journal of Clinical Oncology December 2008, 5 (6) 424-428; DOI: https://doi.org/10.1007/s11805-008-0424-5
  • You have access
    Feasibility Evaluation for Selection of Neoadjuvant Chemotherapy before Cytoreduction of Advanced Ovarian Carcinoma
    Wenying Zhang and Yuezhen Xue
    Chinese Journal of Clinical Oncology December 2007, 4 (6) 433-437; DOI: https://doi.org/10.1007/s11805-007-0433-9
  • You have access
    Investigation of the Effect of Neoadjuvant Chemotherapy on Stage II Breast Cancer
    Yanli Song and Dong Wang
    Chinese Journal of Clinical Oncology April 2007, 4 (2) 142-144; DOI: https://doi.org/10.1007/s11805-007-0142-4
  • You have access
    Short–term Intensive Neoadjuvant Chemotherapy Improving 10–year Survival for Patients with Stage II and Operable Stage III Breast Cancer
    Bin Zhang, Yue Cai, Qi Zhang, Ziwei Ying, Shuling Jiang, Hong Xu, Yongxue Zheng and Daqing Jiang
    Chinese Journal of Clinical Oncology February 2004, 1 (1) 42-46;

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire